PSMA PET/CT与多参数MRI检出前列腺癌的相关临床、病理及影像变量
单中心回顾性分析100例术前同时行PSMA PET/CT与多参数MRI的前列腺癌患者,共132个临床显著前列腺癌病灶。PSMA PET/CT病灶水平敏感度87%高于多参数MRI的80%,患者水平敏感度98%高于94%。多参数MRI未检出而PSMA PET/CT检出的肿瘤较两者均检出者更小。
要点
- PSMA PET/CT病灶水平敏感度87%,多参数MRI为80%。
- PSMA PET/CT患者水平敏感度98%,多参数MRI为94%。
- 多参数MRI漏检而PSMA PET/CT检出的临床显著前列腺癌体积更小。
核心结论
- PSMA PET/CT倾向于检出多参数MRI未检出的较小临床显著前列腺癌。
- 病理上体积较大、分级分组较高的肿瘤更易被两种影像均正确检出。
研究设计与样本
- 单中心回顾性分析,纳入在根治性前列腺切除术前3个月内同时接受PSMA PET/CT与多参数MRI的患者。
- 2名核医学医师与2名放射科医师分别以盲法独立勾画PSMA PET/CT与多参数MRI上的前列腺癌病灶,每种模态由第三名读者共识判读并采用2:1多数规则。
- 集中影像判读后由泌尿生殖病理学家进行病理复核。
- 手术病理共确认来自100例患者的132个临床显著前列腺癌肿瘤。
主要发现
- PSMA PET/CT病灶水平敏感度87% vs 多参数MRI 80%,患者水平敏感度98% vs 94%。
- 两种影像均检出的肿瘤较一种或两种影像未检出者更大且分级分组更高。
- 多因素分析中,多参数MRI未检出而PSMA PET/CT检出的临床显著前列腺癌较多参数MRI与PSMA PET/CT均检出者更小。
- 具有侵袭性病理特征的大筛孔型(94.7%)和导管内癌(96%)多数被两种影像均正确检出。
临床怎么用
- 原文未据此给出推荐。
局限性
- 局限性包括外科手术队列中的选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT are complementary imaging modalities used in the presurgical evaluation of patients with prostate cancer (PCa). The purpose of this study was to characterize clinically significant PCa (csPCa) detected and not detected by PSMA PET/CT and mpMRI, focusing on tumors detected solely by PSMA PET/CT and overlooked by mpMRI. Methods: We conducted a single-center, retrospective analysis of patients who underwent both PSMA PET/CT and mpMRI within 3 mo of each other and before radical prostatectomy. Two nuclear medicine physicians and 2 radiologists, in a masked manner, independently contoured PCa lesions on PSMA PET/CT and mpMRI, respectively. A consensus read was done with a third reader for each modality, and a majority rule was applied (2:1). After centralized imaging, a pathologic review was done by a genitourinary pathologist. We assessed agreement between imaging modalities and correlation with pathology. Logistic regression models explored associations between clinicopathologic variables and tumor detection on imaging. Results: In total, 132 csPCa tumors from 100 patients were identified on surgical pathology. PSMA PET/CT showed higher lesion-level (87% vs. 80%) and patient-level (98% vs. 94%) sensitivity than mpMRI. Tumors detected on both imaging modalities were larger and had higher grade groups than those not detected by one or both imaging modalities. On multivariable analysis, csPCa tumors undetected by mpMRI but detected by PSMA PET/CT were smaller than those detected by both modalities. Most tumors showing aggressive pathologic features, such as the large cribriform pattern (94.7%) and the intraductal carcinoma (96%), were correctly detected by both imaging modalities. Limitations included selection bias in a surgical cohort. Conclusion: PSMA PET/CT tends to detect smaller csPCa not detected by mpMRI. Larger tumors on pathology with higher grade groups are more likely to be correctly detected by both imaging modalities. These findings provide insights for refining presurgical evaluation strategies in PCa.
引用
- Sonni I, Weiner AB, Doddipalli S, et al. Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. J Nucl Med. 2024. PMID: 39477501. doi:10.2967/jnumed.124.268443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。